Trial intelligence / Profile preview

Phase II evaluation of DermaPro for chronic wounds with impaired healing

2007-007748-85Phase 2Terminated

Sponsor
DermaTools Biotech
Start
Feb 2009
Countries
1
01

Overview

Phase 2, randomised, open-label trial of DermaPro in Not applicable, venous stasis, arteriosclerosis obliterans and 3 more (2 arms), sponsored by DermaTools Biotech. Started Feb 2009; status: terminated.

02

Drugs

DermaPro
03

Conditions

Not applicablevenous stasisarteriosclerosis obliteranstype 2 diabetes mellitus (T2DM)diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on 2007-007748-85.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-007748-85.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call